Clinical Trial Update: Locoregional Treatment and Palbociclib in de Novo, Treatment Naive, Stage IV ER+, HER2- Breast Cancer Patients [NA]

View source ↗

Summary

An update on a clinical trial evaluating locoregional treatment with palbociclib for de novo, treatment-naive, stage IV ER-positive, HER2-negative breast cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Palbociclib (palbociclib)

Snippet

Sponsor: UNICANCER | Conditions: Breast Cancer Stage IV, Radiotherapy | NA | Status: ACTIVE_NOT_RECRUITING